{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:48:56Z","timestamp":1790887736799,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,10]],"date-time":"2017-08-10T00:00:00Z","timestamp":1502323200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.ymgme.2017.08.002","type":"journal-article","created":{"date-parts":[[2017,8,4]],"date-time":"2017-08-04T23:35:03Z","timestamp":1501889703000},"page":"122-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["Exploring the patient journey to diagnosis of Gaucher disease from the perspective of 212 patients with Gaucher disease and 16 Gaucher expert physicians"],"prefix":"10.1016","volume":"122","author":[{"given":"Atul","family":"Mehta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Belmatoug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Bembi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Deegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Elstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zlem","family":"G\u00f6ker-Alpan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Lukina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugen","family":"Mengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimitoshi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory M.","family":"Pastores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"P\u00e9rez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Serratrice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6783-2301","authenticated-orcid":false,"given":"Jeffrey","family":"Szer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari","family":"Zimran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Di Rocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoya","family":"Panahloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Kuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derralynn","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2017.08.002_bb0005","series-title":"Williams Hematology","article-title":"Gaucher disease and related lysosomal storage diseases","author":"Zimran","year":"2016"},{"key":"10.1016\/j.ymgme.2017.08.002_bb0010","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1067\/S0022-3476(03)00302-0","article-title":"Phenotypic continuum in neuronopathic Gaucher disease: an intermediate phenotype between type 2 and type 3","volume":"143","author":"Goker-Alpan","year":"2003","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2017.08.002_bb0015","doi-asserted-by":"crossref","first-page":"285","DOI":"10.4155\/cli.10.21","article-title":"Velaglucerase alfa in the treatment of Gaucher disease type 1","volume":"1","author":"Burrow","year":"2011","journal-title":"Clin. Investig. (Lond.)"},{"key":"10.1016\/j.ymgme.2017.08.002_bb0020","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1001\/archinte.160.18.2835","article-title":"The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease","volume":"160","author":"Charrow","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ymgme.2017.08.002_bb0025","first-page":"59","article-title":"Prevalence and management of Gaucher disease","volume":"2","author":"Burrow","year":"2011","journal-title":"Pediatr. Health Med. Ther."},{"key":"10.1016\/j.ymgme.2017.08.002_bb0030","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/ajh.20908","article-title":"Consequences of diagnostic delays in type 1 Gaucher disease: the need for greater awareness among hematologists-oncologists and an opportunity for early diagnosis and intervention","volume":"82","author":"Mistry","year":"2007","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ymgme.2017.08.002_bb0035","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ajh.21888","article-title":"A reappraisal of Gaucher disease-diagnosis and disease management algorithms","volume":"86","author":"Mistry","year":"2011","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ymgme.2017.08.002_bb0040","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.24801","article-title":"Transformation in pretreatment manifestations of Gaucher disease type 1 during two decades of alglucerase\/imiglucerase enzyme replacement therapy in the International Collaborative Gaucher Group (ICGG) Gaucher registry","author":"Mistry","year":"2017","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ymgme.2017.08.002_bb0045","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/000992289503400705","article-title":"Diagnosing Gaucher disease. Early recognition, implications for treatment, and genetic counseling","volume":"34","author":"Sidransky","year":"1995","journal-title":"Clin. Pediatr. (Phila.)"},{"key":"10.1016\/j.ymgme.2017.08.002_bb0050","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2141.2009.07872.x","article-title":"Timing of initiation of enzyme replacement therapy after diagnosis of type 1 Gaucher disease: effect on incidence of avascular necrosis","volume":"147","author":"Mistry","year":"2009","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ymgme.2017.08.002_bb0055","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejim.2013.09.006","article-title":"Gaucher disease: a diagnostic challenge for internists","volume":"25","author":"Cassinerio","year":"2014","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.ymgme.2017.08.002_bb0060","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/bjh.12804","article-title":"Gaucher disease: haematological presentations and complications","volume":"165","author":"Thomas","year":"2014","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ymgme.2017.08.002_bb0065","first-page":"499","article-title":"Outcome of enzyme replacement therapy in Turkish patients with Gaucher disease: does late intervention affect the response?","volume":"53","author":"Arikan-Ayyildiz","year":"2011","journal-title":"Turk. J. Pediatr."},{"key":"10.1016\/j.ymgme.2017.08.002_bb0070","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1182\/blood-2010-06-293902","article-title":"Improvement in hematological, visceral, and skeletal manifestations of Gaucher disease type 1 with oral eliglustat tartrate (Genz-112638) treatment: 2-year results of a phase 2 study","volume":"116","author":"Lukina","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2017.08.002_bb0075","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1399-0004.2008.00978.x","article-title":"Improvement of bone disease by imiglucerase (Cerezyme) therapy in patients with skeletal manifestations of type 1 Gaucher disease: results of a 48-month longitudinal cohort study","volume":"73","author":"Sims","year":"2008","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2017.08.002_bb0080","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/ejh.12596","article-title":"A multicentre observational study for early diagnosis of Gaucher disease in patients with splenomegaly and\/or thrombocytopenia","volume":"96","author":"Motta","year":"2016","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.ymgme.2017.08.002_bb0085","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.bbalip.2013.11.004","article-title":"Gaucher disease and Fabry disease: new markers and insights in pathophysiology for two distinct glycosphingolipidoses","volume":"1841","author":"Ferraz","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2017.08.002_bb0090","unstructured":"Shire, Patient services, At OnePath\u00ae, we're here to help. https:\/\/www.shire.com\/patients\/patient-services\/onepath (Accessed 9 June 2017)."},{"key":"10.1016\/j.ymgme.2017.08.002_bb0095","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s12098-015-2014-x","article-title":"Lysosomal storage disorders in Egyptian children","volume":"83","author":"Elmonem","year":"2016","journal-title":"Indian J. Pediatr."},{"key":"10.1016\/j.ymgme.2017.08.002_bb0100","series-title":"The Online Metabolic and Molecular Bases of Inherited Disease","article-title":"Gaucher disease","author":"Grabowski","year":"2014"},{"key":"10.1016\/j.ymgme.2017.08.002_bb0105","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1001\/archinternmed.2010.302","article-title":"Type 1 Gaucher disease: significant disease manifestations in \u201casymptomatic\u201d homozygotes","volume":"170","author":"Balwani","year":"2010","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ymgme.2017.08.002_bb0110","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0140-6736(11)61266-X","article-title":"Neonatal screening for lysosomal storage disorders: feasibility and incidence from a nationwide study in Austria","volume":"379","author":"Mechtler","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2017.08.002_bb0115","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/8904_2013_229","article-title":"Selective screening for lysosomal storage diseases with dried blood spots collected on filter paper in 4,700 high-risk Colombian subjects","volume":"11","author":"Uribe","year":"2013","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2017.08.002_bb0120","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/8904_2012_130","article-title":"Newborn screening for lysosomal storage disorders in Hungary","volume":"6","author":"Wittmann","year":"2012","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2017.08.002_bb0125","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jpeds.2014.09.023","article-title":"Lysosomal storage disorder screening implementation: findings from the first six months of full population pilot testing in Missouri","volume":"166","author":"Hopkins","year":"2015","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2017.08.002_bb0130","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1373\/clinchem.2016.258459","article-title":"Newborn screening for lysosomal storage disorders: quo vadis?","volume":"62","author":"Peake","year":"2016","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2017.08.002_bb0135","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/pbc.25165","article-title":"Early diagnosis of Gaucher disease in pediatric patients: proposal for a diagnostic algorithm","volume":"61","author":"Di Rocco","year":"2014","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.ymgme.2017.08.002_bb0140","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cca.2008.12.006","article-title":"Rapid diagnostic testing procedures for lysosomal storage disorders: alpha-glucosidase and beta-galactosidase assays on dried blood spots","volume":"402","author":"Gasparotto","year":"2009","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2017.08.002_bb0145","first-page":"3876","article-title":"A global Delphi consensus initiative for early diagnosis of Gaucher disease: key presenting signs and patient co-variables in type 1 disease [abstract]","volume":"128","author":"Kuter","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2017.08.002_bb0150","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.1182\/blood.V128.22.4886.4886","article-title":"Key presenting signs and patient co-variables in early diagnosis of type 3 Gaucher disease: a global Delphi consensus initiative [abstract]","volume":"128","author":"Kuter","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2017.08.002_bb0155","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1016\/j.ymgme.2016.11.235","article-title":"A global Delphi consensus initiative to facilitate early diagnosis of type 1 and type 3 Gaucher disease: what are the phenotypic commonalities? [abstract]","volume":"120","author":"Mehta","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2017.08.002_bb0160","first-page":"1","article-title":"The Delphi technique: making sense of consensus","volume":"12","author":"Hsu","year":"2007","journal-title":"Pract. Assess. Res. Eval."},{"key":"10.1016\/j.ymgme.2017.08.002_bb0165","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/GIM.0b013e3181c39194","article-title":"A validated disease severity scoring system for adults with type 1 Gaucher disease","volume":"12","author":"Weinreb","year":"2010","journal-title":"Genet. Med."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719217303761?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719217303761?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T19:25:34Z","timestamp":1635967534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719217303761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S1096719217303761"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2017.08.002","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the patient journey to diagnosis of Gaucher disease from the perspective of 212 patients with Gaucher disease and 16 Gaucher expert physicians","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2017.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors and Shire HGT Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}